Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSSE Regulatory News (SSE)

Share Price Information for SSE (SSE)

Share Price is delayed by 15 minutes
Get Live Data
2,358.00    -25.00 (-1.05%)
Bid:
2,363.00
Ask:
2,364.00
Spread: 1.00 (0.042%)
Market Cap: £28.44b
SSE Live PriceLast checked at - London Stock Exchange

Intraday SSE Share Chart

Statement re CMA Final Determinations

28 Oct 2021 07:03

RNS Number : 4990Q
SSE PLC
28 October 2021
 

SSE plc

CMA Final Determinations

28 October 2021

 

The CMA has today published a summary of its final determinations into SSEN Transmission's appeal against certain elements of Ofgem's RIIO-T2 price control settlement. The full final determinations and associated documents are expected to be provided to appellants and interveners later this week and then published by the CMA shortly thereafter.

SSEN Transmission welcomes that the CMA has upheld its appeals against the assumed 'Outperformance Wedge', and for changes to the Licence Modification Process.

However, SSEN Transmission is disappointed that the CMA has not upheld its appeals on the flawed Cost of Equity, or on changes to how Transmission Network Use of System Charges are recovered and the associated risk of under recovery this presents.

SSEN Transmission will continue to assess the full details of the CMA's final determinations as they become available and remains committed to work constructively with Ofgem and wider stakeholders as it continues to take forward ambitious plans to deliver a network for net zero.

ENQUIRIES:

Investors and Analysts ir@sse.com +44(0)345 0760 530

Media media@sse.com +44(0)345 0760 530

NOTES TO EDITORS:

SSEN Transmission, operating under licence held by Scottish Hydro Electric (SHE) Transmission plc, owns, operates and develops the high voltage electricity transmission system in the north of Scotland and remote islands.

SSEN Transmission is a wholly owned subsidiary of SSE plc.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRFLFEAIFLDFIL
Date   Source Headline
9th Oct 20249:03 amRNSDirector/PDMR Shareholding
9th Oct 20247:00 amRNSTransaction in Own Shares
8th Oct 20247:00 amRNSTransaction in Own Shares
7th Oct 20247:00 amRNSTransaction in Own Shares
4th Oct 20247:00 amRNSTransaction in Own Shares
3rd Oct 20247:00 amRNSTransaction in Own Shares
3rd Oct 20247:00 amRNSNotification of Closed Period
2nd Oct 202410:47 amRNSDirector/PDMR Shareholding
2nd Oct 20247:00 amRNSTransaction in Own Shares
1st Oct 20243:46 pmRNSTotal Voting Rights
1st Oct 20247:00 amRNSTransaction in Own Shares
30th Sep 202410:03 amRNSNon-Discretionary Share Buyback Programme
25th Sep 20244:38 pmRNSDirector/PDMR Shareholding
23rd Sep 20243:30 pmRNSDirector/PDMR Shareholding
17th Sep 20248:00 amRNSAdditional Listing
10th Sep 20244:44 pmRNSDirector/PDMR Shareholding
3rd Sep 20248:25 amRNSUK Contracts for Difference Allocation Round 6
2nd Sep 20247:00 amRNSTotal Voting Rights
30th Aug 202410:00 amRNSBlock Listing Six Monthly Return
30th Aug 20248:30 amRNSDirector/PDMR Shareholding
29th Aug 202412:00 pmRNSScrip Alternative
28th Aug 20245:12 pmRNSIssuance of Green Bond
9th Aug 202410:57 amRNSDirector/PDMR Shareholding
1st Aug 202411:32 amRNSScrip Dividend Scheme
1st Aug 20247:00 amRNSTotal Voting Rights
30th Jul 20243:41 pmRNSHolding(s) in Company
22nd Jul 20249:06 amRNSHolding(s) in Company
18th Jul 20244:16 pmRNSResult of AGM
18th Jul 20247:31 amRNSOfgem RIIO-3 Sector Specific Methodology Decision
18th Jul 20247:00 amRNSQ1 Trading Statement
10th Jul 20243:36 pmRNSDirector/PDMR Shareholding
10th Jul 20249:28 amRNSDirector/PDMR Shareholding
9th Jul 20243:26 pmRNSDirector/PDMR Shareholding
9th Jul 20247:00 amRNSSSE & partners advance 2GW offshore windfarm in NL
1st Jul 20249:25 amRNSTotal Voting Rights
14th Jun 20241:00 pmRNSAnnual Financial Report
14th Jun 202411:22 amRNSDirector/PDMR Shareholding
10th Jun 20243:40 pmRNSDirector/PDMR Shareholding
3rd Jun 20244:15 pmRNSDirector/PDMR Shareholding
3rd Jun 20247:00 amRNSTotal Voting Rights
23rd May 20249:23 amRNSDividend Timetable
23rd May 20247:01 amRNSDirector Declaration
22nd May 20247:00 amRNSPreliminary Results for the year ended 31 March 24
8th May 202412:05 pmRNSDirector/PDMR Shareholding
1st May 20247:00 amRNSTotal Voting Rights
10th Apr 20244:22 pmRNSDirector/PDMR Shareholding
9th Apr 20242:31 pmRNSDirector/PDMR Shareholding
2nd Apr 20249:37 amRNSTotal Voting Rights
27th Mar 20247:00 amRNSNotification of Closed Period
19th Mar 202411:00 amRNSSSEN Transmission welcomes ‘Beyond 2030’ plan

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.